"A Deep Dive: The Breast Cancer Pill" - Pat Farnack
Research of a new breast cancer pill, Olaparib, found that it can be used to treat a certain rare form of breast cancer. Charles Shapiro, MD, director of cancer survivorship and translational breast cancer research at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai said, ”the more we take a deep dive into the growth of these cells, the more we find that these breast cancers are different. Each woman has a unique breast cancer, instead of targeting that cancer with chemotherapy; we need to find the actual defect and targeting therapy based on the genes that make the tumor thick.” This breast cancer pill can be given to certain breast cancer populations instead of chemotherapy.
- Charles Shapiro, MD, Director, Cancer Survivorship, Translational Breast Cancer Research, The Tisch Cancer Institute, Professor, Medicine, Icahn School of Medicine at Mount Sinai
Study Reveals New Insights Into Immune System Role in Lung Cancer Risk
Feb 22, 2024 View All Press ReleasesMount Sinai’s Staten Island Cancer Center Moves to New Site
Nov 09, 2023 View All Press Releases
Scientists Create Most Powerful, Accurate Tool Yet to Research Deadliest Blood Cancer
Apr 18, 2023 View All Press Releases
Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T
Nov 04, 2022 View All Press Releases
Study Identifies New Gene That Drives Colon Cancer
Oct 14, 2022 View All Press Releases